EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic

Yuanzhi Zhao, Xiangping Wu, Min Tang, Lingli Shi, Shuang Gong, Xi Mei, Zheng Zhao, Jiayue He, Ling Huang, Wei Cui

Frontiers in Psychiatry · 06.04.2023 · 14

DOI: 10.3389/fpsyt.2023.1017203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 06.04.2023. Verfasst von Yuanzhi Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Kangning Hospital, Ningbo, Zhejiang, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Ningbo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Late-life depression (LLD) is one of the most common mental disorders among the older adults. Population aging, social stress, and the COVID-19 pandemic have significantly affected the emotional health of older adults, resulting in a worldwide prevalence of LLD. The clinical phenotypes between LLD and adult depression differ in terms of symptoms, comorbid physical diseases, and coexisting cognitive impairments. Many pathological factors such as the imbalance of neurotransmitters, a decrease in neurotrophic factors, an increase in β-amyloid production, dysregulation of the hypothalamic-pituitary-adrenal axis, and changes in the gut microbiota, are allegedly associated with the onset of LLD. However, the exact pathogenic mechanism underlying LLD remains unclear. Traditional selective serotonin reuptake inhibitor therapy results in poor responsiveness and side effects during LLD treatment. Neuromodulation therapies and complementary and integrative therapies have been proven safe and effective for the treatment of LLD. Importantly, during the COVID-19 pandemic, modern digital health intervention technologies, including socially assistive robots and app-based interventions, have proven to be advantageous in providing personal services to patients with LLD.

Schlagwörter

Stichwörter der Autor:innen

COVID-19 pandemicepidemiologylate-life depression (LLD)pathogenesisphenotypetreatment

Autor:innen und Institutionen

  • Ningbo Kangning Hospital, Ningbo, Zhejiang, China.
  • Department of Neurology, Ningbo Rehabilitation Hospital, Ningbo, Zhejiang, China.
  • Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, Translational Medicine Center of Pain, Emotion and Cognition, School of Medicine, Ningbo University, Ningbo, Zheji…

Förderung

  • Natural Science Foundation of Ningbo

Zitieren

APA

Zhao, Y., Wu, X., Tang, M., Shi, L., Gong, S., Mei, X., Zhao, Z., He, J., Huang, L., & Cui, W. (2023). Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1017203

Vancouver

Zhao Y, Wu X, Tang M, Shi L, Gong S, Mei X, et al. Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1017203

BibTeX
@article{Zhao2023,
  author = {Zhao, Yuanzhi and Wu, Xiangping and Tang, Min and Shi, Lingli and Gong, Shuang and Mei, Xi and Zhao, Zheng and He, Jiayue and Huang, Ling and Cui, Wei},
  title = {Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic},
  journal = {Frontiers in Psychiatry},
  year = {2023},
  volume = {14},
  doi = {10.3389/fpsyt.2023.1017203}
}
Kostenlos starten →